neostigmine has been researched along with Hyperplasia of Thymus Gland in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prasad, KP | 1 |
| Alahakoon, DG | 1 |
| Vidanagama, U | 1 |
| ADLER, E | 1 |
2 other studies available for neostigmine and Hyperplasia of Thymus Gland
| Article | Year |
|---|---|
Case of generalised myasthenia gravis with membranous nephropathy.
Topics: Adult; Blepharoptosis; Female; Glomerulonephritis, Membranous; Humans; Kidney Failure, Chronic; Myas | 2008 |
[THE THYMUS-MYASTHENIA PROBLEM FROM THE VIEWPOINT OF THE SURGEON].
Topics: Drug Therapy; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Surgeons; Thymectomy; Thymoma | 1965 |